C&F Financial Corporation has delivered a 53.3% total return since September 2025, driven by strong asset quality and a net interest margin above last year's levels. The company's loan portfolio is shifting towards commercial real estate, now making up 44.1% of loans, while auto loans have declined to 18.8%. Although the stock no longer trades at a discount and is above tangible book value, the company's fundamentals remain solid, supporting a Buy rating.
C&F Financial Corporation's recent performance is presented here as context for readers. Among 142 Financials-sector US stocks tradable on Pluang, 83 rose and 22 fell today. Notably, MUFG gained 2.05% to USD 21.40 with a typical hold time of 11 days, contrasting with MARA and HOOD, which declined by 2.36% and 2.09% respectively, as of Nov 09, 2026 16:11 WIB.
ISS A/S is actively executing its share buyback program announced in February 2026, aiming to redistribute excess cash to shareholders and reduce share capital. As of early November 2026, the company has repurchased approximately 7.69 million shares ...
AL Sydbank A/S executed transactions to buy back 30,000 shares during week 45 as part of its ongoing share buyback program announced in February 2026, which totals DKK 1.1 billion. The program started in March 2026 and will conclude by January 2027, ...
AL Sydbank A/S continued its share buyback program in week 45, purchasing 30,000 shares at an average price of around 725 DKK, totaling approximately 21.76 million DKK. The buyback program, announced in February 2026 and running until January 2027, a...
Oculis Holding AG announced an in-person and virtual R&D Day on December 8, 2026, to highlight key clinical developments in its late-stage pipeline, including Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmology and neurology. The...
Oculis Holding AG will hold a Research & Development Day on December 8, 2026, to present key clinical progress on its late-stage drug candidates Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmic conditions including optic neuritis...
